Phoenix Financial Ltd.

Position in GILD — Gilead Sciences, Inc.

CIK 1679543 Givatayim, L3

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$3,072,083

+$245,799 QoQ

Shares Held

24,316

+19.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#711

of 2,266 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Phoenix Financial Ltd. holds $174,300,668 across 10 Drug Manufacturers - General names. GILD ranks #9 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	97,019	$116,367,508
2	ABBV	AbbVie Inc.	47,441	$11,938,053
3	JNJ	Johnson & Johnson	46,830	$11,893,414
4	NVO	Novo Nordisk A S	158,343	$7,590,962
5	MRK	Merck & Co., Inc.	52,551	$6,752,803
6	BMY	Bristol Myers Squibb Co	114,254	$6,583,314
7	PFE	Pfizer Inc	253,976	$6,115,741
8	AZN	Astrazeneca PLC	19,365	$3,671,991

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,072,083	24,316	+19.9%	Shares	Sole	2026-08-11
2026-03-31	$2,826,284	20,279	+67.3%	Shares	Sole	2026-05-11
2025-12-31	$1,488,099	12,124	+8.6%	Shares	Sole	2026-02-05
2025-09-30	$1,238,871	11,161	+10.6%	Shares	Sole	2025-11-13
2025-06-30	$1,119,121	10,094	+5.9%	Shares	Sole	2025-07-30
2025-03-31	$1,067,836	9,530	+141.6%	Shares	Sole	2025-05-07
2024-12-31	$364,399	3,945	-76.8%	Shares	Sole	2025-02-13
2024-09-30	$1,427,292	17,024	-45.3%	Shares	Sole	2024-11-05
2020-09-30	$1,966,093	31,114	+11.1%	Shares	Defined	2020-11-10
2020-06-30	$2,155,551	28,016	-32.8%	Shares	Defined	2020-08-10
2020-03-31	$3,116,819	41,691	—	Shares	Defined	2020-05-20
No filing history on record for this holder in this stock.